共 50 条
Pathogenesis of myeloma bone disease
被引:278
|作者:
Roodman, G. D.
[1
]
机构:
[1] Univ Pittsburgh, Vet Affairs Pittsburgh Healthcare Syst, Dept Med Hematol Oncol, Sch Med, Pittsburgh, PA 15240 USA
来源:
关键词:
multiple myeloma;
osteoclast;
osteoblast;
bone disease;
KAPPA-B LIGAND;
OSTEOCLAST DIFFERENTIATION FACTOR;
TUMOR-NECROSIS-FACTOR;
MULTIPLE-MYELOMA;
RECEPTOR ACTIVATOR;
IN-VIVO;
INHIBITS OSTEOCLASTOGENESIS;
OSTEOBLAST DIFFERENTIATION;
MARROW MICROENVIRONMENT;
PROTEASOME INHIBITOR;
D O I:
10.1038/leu.2008.336
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Bone disease in multiple myeloma (MM) is characterized by lytic bone lesions, which can cause severe bone pain, pathologic fractures and hypercalcemia. However, the lytic bone disease in MM differs from that in other cancer patients who have lytic bone metastases. Although increased osteoclastic bone destruction is involved in MM and other tumors involving bone, in contrast to other tumors, once the MM tumor burden exceeds 50% in a local area, osteoblast activity is either suppressed or absent. 1 The basis for this severe imbalance between increased osteoclastic bone resorption and decreased bone formation has been a topic of intensive investigation over the last several years and will be reviewed in this article.
引用
收藏
页码:435 / 441
页数:7
相关论文